CAPTRUST Financial Advisors
TPTX

CAPTRUST Financial Advisors’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-195
Closed -$15K – 4603
2022
Q2 		$15K Sell
195
-850
-81% -$37.8K ﹤0.01% 3545
2022
Q1 		$28K Buy
1,045
+667
+176% +$22.4K ﹤0.01% 3206
2021
Q4 		$18K Buy
378
+355
+1,543% +$15.9K ﹤0.01% 3385
2021
Q3 		$2K Hold
23
– – ﹤0.01% 4334
2021
Q2 		$2K Hold
23
– – ﹤0.01% 4239
2021
Q1 		$2K Buy
+23
New +$2.73K ﹤0.01% 4101

CAPTRUST Financial Advisors's TPTX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 195 shares — an estimated $15K sold.

CAPTRUST Financial Advisors first reported a position in TPTX in Q1 2021 and held it in 6 quarters. The position peaked at $28K in Q1 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 195 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $15K.
  • CAPTRUST Financial Advisors first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Turning Point Therapeutics, Inc. Common Stock position peaked at $28K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.